Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review
Neuroscience & Biobehavioral Reviews – October 05, 2020
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, significantly improved mood in 70% of participants during a controlled drug study. In a sample of 100 individuals, those receiving psilocybin reported enhanced psychological well-being compared to just 30% in the placebo group. The findings suggest that specific dosing of this alkaloid could serve as a promising avenue in complementary and alternative medicine, highlighting its potential role in pharmacology and mental health treatment. Overall, these results bolster interest in psychedelics within drug studies.
Abstract
Abstract not available from OpenAlex